IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 124 filers reported holding IMMUNOVANT INC in Q3 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $14,000 | -12.5% | 3,597 | +22.7% | 0.00% | – |
Q1 2022 | $16,000 | -51.5% | 2,931 | -24.7% | 0.00% | -100.0% |
Q4 2021 | $33,000 | -44.1% | 3,892 | -42.8% | 0.00% | 0.0% |
Q3 2021 | $59,000 | -52.4% | 6,809 | -42.3% | 0.00% | -50.0% |
Q2 2021 | $124,000 | -53.2% | 11,798 | -28.6% | 0.00% | -60.0% |
Q1 2021 | $265,000 | -74.0% | 16,526 | -25.2% | 0.01% | -79.2% |
Q4 2020 | $1,020,000 | +862.3% | 22,104 | +682.7% | 0.02% | +500.0% |
Q3 2020 | $106,000 | – | 2,824 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 1,439,544 | $22,327,327 | 8.67% |
Logos Global Management LP | 2,500,000 | $38,775,000 | 5.55% |
Deep Track Capital, LP | 7,432,717 | $115,281,441 | 4.74% |
COMMODORE CAPITAL LP | 1,440,999 | $22,349,894 | 3.40% |
Ikarian Capital, LLC | 774,398 | $12,010,913 | 2.72% |
COWEN AND COMPANY, LLC | 1,250,000 | $19,387,500 | 2.28% |
HighVista Strategies LLC | 163,799 | $2,540,522 | 2.07% |
TCG Crossover Management, LLC | 654,853 | $10,156,770 | 1.98% |
BVF INC/IL | 2,561,000 | $39,721,110 | 1.45% |
Redmile Group, LLC | 1,317,031 | $20,427,151 | 0.89% |